Recombinant DNA polymerase, preparation method, kit and application in probe method qPCR amplification

By fusing the 5'-3' nucleic acid exochondrial active domain on KOD DNA polymerase and optimizing it, a recombinant DNA polymerase with high anti-inhibitory ability and thermal stability was obtained, and DNA polymerase in probe qPCR was solved The problems of poor anti-inhibition ability and insufficient thermal stability have achieved efficient detection of complex samples.

CN118931868AActive Publication Date: 2024-11-12THIRD INSTITUTE OF OCEANOGRAPHY STATE OCEANI C ADMINISTRATION
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411197722.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-29
Publication Date
2024-11-12
Estimated Expiration
2044-08-29

AI Technical Summary

Technical Problem

The anti-inhibitory ability of DNA polymerase in existing probe method qPCR is poor and the thermal stability is not ideal, making it difficult to effectively apply to the detection of complex samples.

Method used

By fusing a domain with 5'-3' nucleic acid exocatalytic activity on the KOD DNA polymerase and performing structural optimization, a recombinant DNA polymerase with excellent anti-inhibitory ability and thermal stability is obtained for probes Method qPCR detection.

Benefits of technology

Qualitative and quantitative detection of complex samples has been achieved, and the specificity and accuracy of the detection has been improved, especially in clinical diagnosis and food safety testing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005016963020000061
    Figure BDA0005016963020000061
  • Figure BDA0005016963020000071
    Figure BDA0005016963020000071
  • Figure BDA0005016963020000081
    Figure BDA0005016963020000081
Patent Text Reader

Abstract

The invention belongs to the technical field of molecular biology, and discloses a recombinant DNA polymerase, a preparation method, a kit and application in qPCR (quantitative polymerase chain reaction) amplification by a probe method. The recombinant DNA polymerase provided by the invention comprises an amino acid fragment with a sequence as shown in SEQ ID NO: 1 and / or a variant sequence with more than 90% of homology with the amino acid fragment as shown in SEQ ID NO: 1. The recombinant DNA polymerase has excellent anti-inhibition ability and thermal stability, can be well applied to probe method qPCR to realize qualitative and quantitative detection of a target sequence in a sample to be detected, especially has a good detection effect on a complex sample, and has important significance in application in the fields of clinical diagnosis, food safety detection and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of molecular biology, and in particular relates to a recombinant DNA polymerase, a preparation method, a kit and an application in probe-based qPCR amplification. Background Art

[0002] qPCR technology refers to a technology that introduces fluorescent chemicals on the basis of traditional polymerase chain reaction. By detecting the changes in the intensity of the fluorescent signal in the reaction system, it can achieve quantitative detection of the amplification product. It is widely used in various fields of life sciences such as clinical disease diagnosis, environmental sample testing, food safety testing, and biological research.

[0003] According to the way the fluorescent signal is generated in qPCR technology, it can be divided into dye-based qPCR and probe-based qPCR. Among them, the cost of dye-based qPCR is low, but the non-specific amplification in the reaction has a particularly large impact on the test results, and the false positive rate is high. Compared with dye-based qPCR, the probe-based qPCR uses the specific binding ability of probes with fluorescent chemicals to the target sequence, which can effectively reduce the impact of non-specific amplification in the reaction on the test results. It has the advantages of high specificity, high accuracy and short time consumption, and is therefore more widely used in biomedical diagnosis, pathogen detection, agricultural science, food safety and other fields.

[0004] At present, the DNA polymerase used in probe-based qPCR is Taq DNA polymerase, which has 5'-3' exonuclease activity and can degrade the probe bound to the target sequence during DNA chain extension, so that the fluorescent quencher group and the fluorescent reporter group are separated, thereby generating a fluorescent signal. However, the Taq DNA polymerase has poor anti-inhibition ability and unsatisfactory thermal stability, and cannot be well applied to probe-based qPCR detection of complex samples, which has great limitations. Summary of the invention

[0005] The first purpose of the present invention is to provide a recombinant DNA polymerase in order to solve the problems of poor inhibition resistance and low thermal stability of DNA polymerase in the existing probe method qPCR.

[0006] The second object of the present invention is to provide a method for preparing the above-mentioned recombinant DNA polymerase.

[0007] The third object of the present invention is to provide the use of the above-mentioned recombinant DNA polymerase in probe-based qPCR amplification.

[0008] Specifically, the recombinant DNA polymerase provided by the present invention includes an amino acid fragment as shown in SEQ ID NO:1 and / or a variant sequence having more than 90% homology with the amino acid fragment as shown in SEQ ID NO:1.

[0009] Furthermore, the amino acid sequence of the recombinant DNA polymerase is shown in SEQ ID NO:1.

[0010] The preparation method of the above-mentioned recombinant DNA polymerase provided by the present invention comprises: S1, taking the coding gene of the recombinant DNA polymerase and recombining it into a plasmid vector to obtain a recombinant plasmid; S2, taking the recombinant plasmid and introducing it into a host cell to obtain an enzyme expression strain; S3, taking the enzyme expression strain and inducing expression to obtain the recombinant DNA polymerase.

[0011] Furthermore, in step S1, the nucleotide sequence of the gene encoding the recombinant DNA polymerase is shown in SEQ ID NO:2.

[0012] Furthermore, in step S1, the plasmid vector is selected from one or more of pET-28a, pET-24a, pET-24b and pET-24c.

[0013] Furthermore, in step S2, the host cell is selected from one or more of Escherichia coli DH5α, Escherichia coli BL21 and Escherichia coli BL21 (DE3).

[0014] Furthermore, in step S3, the induced expression includes: taking the enzyme expression strain for expansion culture to obtain a seed solution; taking an inducing expression agent and adding it to the seed solution for induced expression culture to obtain the recombinant DNA polymerase.

[0015] Furthermore, the inoculation amount of the enzyme expression strain for the expanded culture is 1-3%, the temperature is 35-40° C., and the time is 12-48 hours.

[0016] Furthermore, the inducing agent is IPTG, and the final concentration of the addition is 0.05-0.2 mM.

[0017] Furthermore, the induction expression culture temperature is 25-30°C and the time is 16-18 hours.

[0018] The present invention also provides application of the recombinant DNA polymerase in probe-based qPCR amplification.

[0019] The probe method qPCR amplification reaction kit provided by the present invention comprises the above-mentioned recombinant DNA polymerase.

[0020] Beneficial effects:

[0021] The recombinant DNA polymerase provided by the present invention includes an amino acid fragment as shown in SEQ ID NO:1 and / or a variant sequence having more than 90% homology with the amino acid fragment as shown in SEQ ID NO:1. The recombinant DNA polymerase has excellent anti-inhibition ability and thermal stability, and can be well applied to probe-based qPCR to achieve qualitative and quantitative detection of target sequences in samples to be tested, especially for complex samples, and has a good detection effect, and is of great significance in applications in the fields of clinical diagnosis, food safety detection, etc. DETAILED DESCRIPTION

[0022] The inventors of the present invention aim to "obtain a DNA polymerase having both 5'-3' exonuclease activity and excellent anti-inhibition ability and thermal stability, so as to be applied to probe-based qPCR, especially having good detection effect on complex samples". After extensive and in-depth research, the inventors creatively fused a domain having 5'-3' exonuclease catalytic activity to the structurally optimized KOD DNA polymerase, and performed structural optimization, thereby obtaining the recombinant DNA polymerase provided by the present invention. The recombinant DNA polymerase has good 5'-3' exonuclease activity, as well as excellent anti-inhibition ability and thermal stability.

[0023] In the present invention, the recombinant DNA polymerase includes an amino acid fragment as shown in SEQ ID NO: 1 and / or a variant sequence having more than 90% homology with the amino acid fragment as shown in SEQ ID NO: 1. The variant sequence is obtained by substituting, deleting or adding one or more amino acids in the amino acid sequence as shown in SEQ ID NO: 1, and the substitution, deletion or addition does not affect the biological activity of the recombinant DNA polymerase.

[0024] In some specific embodiments, the recombinant DNA polymerase preferably includes an amino acid fragment with a sequence as shown in SEQ ID NO: 1 and a His tag connected to the N-terminus or C-terminus of the amino acid fragment shown in SEQ ID NO: 1. In this case, the His tag introduced into the recombinant DNA polymerase is conducive to its purification, thereby achieving the effect of improving the purity of the recombinant DNA polymerase.

[0025] In some specific embodiments, the amino acid sequence of the recombinant DNA polymerase is preferably as shown in SEQ ID NO: 1. In this case, the spatial structure of the recombinant DNA polymerase is relatively ideal, and has better enzyme activity, anti-inhibition ability and thermal stability.

[0026] Based on the purpose of obtaining the above-mentioned recombinant DNA polymerase, the present invention also provides a method for preparing the recombinant DNA polymerase. The preparation method comprises: S1, taking the coding gene of the recombinant DNA polymerase and recombining it into a plasmid vector to obtain a recombinant plasmid; S2, taking the recombinant plasmid and introducing it into a host cell to obtain an enzyme expression strain; S3, taking the enzyme expression strain and inducing expression to obtain the recombinant DNA polymerase.

[0027] In the present invention, the nucleotide sequence of the gene encoding the recombinant DNA polymerase can be deduced based on the amino acid sequence of the recombinant DNA polymerase, and due to the degeneracy of the codons, it has diversity. Those skilled in the art can make adaptive designs based on actual conditions. The present invention does not impose any particular limitation on the nucleotide sequence of the gene encoding the recombinant DNA polymerase.

[0028] In some specific embodiments, the nucleotide sequence of the gene encoding the recombinant DNA polymerase is shown in SEQ ID NO: 2. At this time, the nucleotide sequence of the gene encoding the recombinant DNA polymerase is codon-optimized for Escherichia coli, so that the recombinant DNA polymerase can be better expressed in Escherichia coli, a common host cell for genetic engineering, thereby obtaining a large amount of recombinant DNA polymerase.

[0029] In the present invention, the plasmid vector is a type of small circular double-stranded DNA molecule, which is independent of the chromosomal DNA of the host cell and can be replicated and transcribed in the host cell. It is a tool commonly used in genetic engineering. Those skilled in the art can make adaptive choices based on actual needs. The present invention does not impose any particular limitation on the plasmid vector.

[0030] In some specific embodiments, specific examples of the plasmid vector include but are not limited to one or more of pET-28a, pET-24a, pET-24b and pET-24c.

[0031] In the present invention, "recombining the coding gene of the recombinant DNA polymerase into a plasmid vector" means using a restriction enzyme to cut the coding gene of the recombinant DNA polymerase and the plasmid vector so that the two produce homologous ends, and using the homologous ends to achieve splicing of the recombinant DNA polymerase and the plasmid vector to obtain the recombinant plasmid. This is a technology routinely used in the field of genetic engineering and the present invention does not impose any particular limitation on it.

[0032] In the present invention, the host cell is a cell used to carry and express the coding gene of the recombinant DNA polymerase, which has a protein expression system for synthesizing the recombinant DNA polymerase. Specifically, it can be a prokaryotic cell such as Escherichia coli, or a eukaryotic cell such as yeast and mammalian cells. It is a tool routinely used in the field of genetic engineering. Those skilled in the art can make adaptive choices according to actual needs. The present invention does not impose any particular limitation on the host cell.

[0033] In some specific embodiments, specific examples of the host cell include but are not limited to: one or more of Escherichia coli DH5α, Escherichia coli BL21 and Escherichia coli BL21 (DE3).

[0034] In the present invention, "introducing the recombinant plasmid into the host cell" means temporarily destroying or changing the cell membrane of the host cell by chemical reagents, gene guns, electroporation, virus vector-mediated infection, liposome mediation and other technical means, so that the recombinant plasmid can enter the cell and the host cell can express the recombinant DNA polymerase. It is a technology routinely used in the field of genetic engineering and the present invention does not impose any special limitation on it.

[0035] In the present invention, the induced expression is to activate the regulatory elements on the recombinant plasmid using specific induction conditions, thereby initiating the expression of the coding gene of the recombinant DNA polymerase in the host cell. It is a technology commonly used in the field of genetic engineering and the present invention does not impose any particular limitation on it.

[0036] In the present invention, the induced expression preferably comprises: taking the enzyme expression strain for expansion culture to obtain seed liquid; taking an inducing expression agent and adding it to the seed liquid for induced expression culture to obtain the recombinant DNA polymerase.

[0037] In the present invention, the expanded culture is to activate the enzyme expression strain and also to make the cell density in the culture medium in a more ideal state, which is conducive to the subsequent induced expression culture. It is a technology commonly used in the field of genetic engineering and is not particularly limited by the present invention.

[0038] In some specific embodiments, the conditions for expanded culture include that the inoculation amount of the enzyme expression strain is preferably 1-3%, such as 1%, 1.05%, 1.3%, 1.5%, 2%, 2.5%, 3% or any value therebetween; the temperature is preferably 35-40°C, such as 35°C, 36°C, 37°C, 38°C, 39°C, 40°C or any value therebetween; and the time is 12-48h, such as 12h, 14h, 18h, 20h, 25h, 30h, 38h, 40h, 48h or any value therebetween.

[0039] In the present invention, the inducing expression agent is used to activate the regulatory elements on the recombinant plasmid, thereby starting the expression of the coding gene of the recombinant DNA polymerase in the host cell. This is a technology commonly used in the field of genetic engineering and is not particularly limited in the present invention.

[0040] In some specific embodiments, the inducing expression agent is preferably IPTG, and its final added concentration is preferably 0.05-0.2 mM, such as 0.05 mM, 0.08 mM, 0.1 mM, 0.13 mM, 0.18 mM, 0.2 mM or any value therebetween.

[0041] In some specific embodiments, the conditions for induced expression culture include a temperature of preferably 25 to 30°C, such as 25°C, 26°C, 28°C, 29°C, 30°C or any value therebetween; and a time of preferably 16 to 18h, such as 16h, 16.3h, 17h, 17.5h, 18h or any value therebetween.

[0042] Based on the 5'-3' exonuclease activity, excellent anti-inhibition ability and thermal stability of the above recombinant DNA polymerase, the present invention also provides the use of the recombinant DNA polymerase in probe-based qPCR amplification.

[0043] Based on the application of the above recombinant DNA polymerase in probe-based qPCR amplification, the present invention also provides a probe-based qPCR amplification reaction kit, which includes the above recombinant DNA polymerase.

[0044] Embodiments of the present invention are described in detail below, and the examples of the embodiments are intended to be used to explain the present invention, but should not be construed as limiting the present invention. In the embodiments, if specific techniques or conditions are not specified, the techniques or conditions described in the literature in this area or the product specifications are used. If the manufacturer is not specified for reagents or instruments used, they are all conventional products that can be obtained commercially.

[0045] The amino acid and nucleotide sequences involved in the present invention are shown in Table 1.

[0046]

[0047]

[0048]

[0049] Example 1

[0050] This example is used to illustrate a recombinant DNA polymerase and its preparation. The amino acid sequence of the recombinant DNA polymerase is shown in SEQ ID NO: 1. The preparation thereof specifically includes:

[0051] 1. Preparation of recombinant plasmid: (1) Based on the amino acid sequence of the recombinant DNA polymerase, the Escherichia coli codon is optimized and synthesized to obtain the coding gene of the recombinant DNA polymerase (the nucleotide sequence is shown in SEQ ID NO: 2);

[0052] (2) adding NdeⅠ and XhoⅠ restriction sites at both ends of the gene encoding the recombinant DNA polymerase, respectively, and synthesizing it, and then digesting it with NdeⅠ and XhoⅠ enzymes and recombining it into the vector pET24a(+) with a His tag to obtain a recombinant plasmid;

[0053] (3) The recombinant plasmid was transformed into Escherichia coli DH5α using a bacterial transformation kit (Thermo Fisher Scientific, catalog number K2711) and referred to the instructions. The plasmid was placed in LB liquid culture medium (Solabo, catalog number L1010) and cultured overnight at 37°C and 200 rpm with shaking. The plasmid was extracted from the culture medium using a plasmid extraction kit (Merck, catalog number PLN350) and referred to the instructions to obtain a large amount of recombinant plasmid.

[0054] 2. Preparation of enzyme expression strain: The recombinant plasmid was transformed into Escherichia coli BL21 (DE3) using a bacterial transformation kit, and the transformed cells were inoculated into LB liquid culture medium containing 50 mg / L kanamycin sulfate, and cultured overnight at 37°C and 200 rpm to obtain an enzyme expression strain.

[0055] 3. Preparation of recombinant DNA polymerase: (1) Inoculate the expression strain into fresh LB liquid medium containing 50 mg / L kanamycin sulfate at a 1% inoculum volume, and culture at 37°C and 200 rpm for 12 h to obtain seed solution;

[0056] (2) Adjust the OD of the seed solution 600 to 0.8, then add IPTG with a final concentration of 0.1 mmol / mL, and culture at 18°C ​​and 200 rpm for 16 h to obtain the induced expression culture solution;

[0057] (3) The induced expression culture medium was centrifuged at 4°C and 10,000 rpm for 10 min to collect the cell mud; 1 g of the cell mud was resuspended in 5 mL of 50 mM Tris-HCl buffer (pH = 7.5), and the cells were ultrasonically disrupted in an ice bath for 10 min in the form of working 4 s and resting 4 s, and centrifuged at 4°C and 10,000 rpm for 10 min, and the supernatant was collected to obtain a crude enzyme solution;

[0058] (4) Purify the crude enzyme solution using a Ni-NTA affinity chromatography column (Shanghai Biotechnology, catalog number C597593) according to the instructions to obtain a pure enzyme solution, and freeze-dry the pure enzyme solution at -80°C to obtain a recombinant DNA polymerase.

[0059] Example 2

[0060] This example is used to illustrate the thermal stability of the recombinant DNA polymerase provided in Example 1, and the commercially available Taq DNA polymerase (Yingxin Laboratory, catalog number TX20089) is used for the test. The test specifically includes:

[0061] (1) Recombinant DNA polymerase and Taq DNA polymerase were mixed with nuclease-free water to prepare a test enzyme solution with a concentration of 0.05 μg / μL. The test enzyme solution was incubated at 90°C for 0, 2, 4, 6, 8 and 10 h, and then the enzyme catalyzed reaction was carried out at 74°C for 30 min using salmon sperm DNA as a template / primer. After the reaction was completed, the solution was immediately placed on ice to terminate the reaction.

[0062] The reaction system of the enzyme-catalyzed reaction includes 1 ng of salmon sperm DNA, 200 μmol / L of dNTPs, 1 μCi [α-32P] of dCTP, 20 mmol / L of Tris-HCl, 2 mmol / L of MgCl2, 5 mmol / L of (NH4)2SO4, 10 mmol / L of KCl, 0.1 g / L of BSA and 0.05% of Triton X-100, pH 8.0.

[0063] (2) Take 5 μL of the reaction product and add it to the ion exchange paper disk. After the spot is dried, rinse it three times with 2×SSC buffer (including 300 mmol / L NaCl and 30 mmol / L Na3C6H5O7, pH7.0), and finally wash it once with anhydrous ethanol after ice bath and dry it. The infiltrated radioactive substances are measured with a liquid scintillation counter. Among them, 1 enzyme activity unit (1U) is defined as the amount of enzyme that catalyzes the incorporation of 10 nmol of dNTPs into DNA. The results are shown in Table 2.

[0064] Table 2.

[0065]

[0066] From the test results shown in Table 2, it can be seen that compared with the existing known Taq DNA polymerase, the enzyme activity of the recombinant DNA polymerase provided in Example 1 of the present invention is as high as 16.59 U / mL, which has excellent enzyme activity, and the half-life of the recombinant DNA polymerase at 90°C is about 8h, which has excellent thermal stability.

[0067] Example 3

[0068] This example is used to illustrate the anti-inhibition ability of the recombinant DNA polymerase provided in Example 1, and the commercially available Taq DNA polymerase (Yingxin Laboratory, catalog number TX20089) is used. The test specifically includes:

[0069] (1) Respectively taking recombinant DNA polymerase and Taq DNA polymerase and mixing them with nuclease-free water to prepare a test enzyme solution with a concentration of 0.05 μg / μL;

[0070] (2) Mix the vector pUC19 with nuclease-free water to obtain a concentration of 1×10 6 copies / μL of the DNA sample I to be tested; 1 mL of the collected sputum was mixed with 0.1 mL of sodium hydroxide solution (0.1 M), liquefied for 30 min, and 10 mL of Tris-HCl buffer (1 mM, pH = 7.5) was added and mixed evenly to obtain an interference solution; the final concentration was 1×10 6 The vector pUC19 was added in an amount of copies / μL and mixed with the interference solution to obtain the DNA sample II to be tested;

[0071] (3) Using the primer-probe system shown in Table 3, qPCR amplification is performed on the DNA sample I and the DNA sample II to be tested, and the CT value of the sample to be tested is obtained according to the measured fluorescence signal.

[0072] Table 3.

[0073] name sequence Primer pUC19F 5'-CCAGGCTTTACACTTTATGC-3' Primer pUC19R 5'-TGGCTTAACTATGCGGCATC-3' Probe 5'-HEX-GCGCGTCAGCGGGTGTTGGCGGGTGTC-BHQ1-3'

[0074] The qPCR amplification reaction system includes: 2 μL of DNA sample I (or II) to be tested, 0.4 μL of dNTP (10 mM), 10 μL of 2×PCR buffer, 0.4 μL of upstream and downstream primers (10 μM), 0.4 μL of probe (10 μM), 1 μL of enzyme solution, and ddH2O is added to 20 μL. The PCR reaction program includes: 95°C pre-denaturation for 3 min; 45 cycles; 95°C denaturation for 10 s, 55°C annealing and extension for 30 s. The results are shown in Table 4.

[0075] Table 4.

[0076]

[0077] From the test results shown in Table 4, it can be seen that compared with the existing Taq DNA polymerase, the recombinant DNA polymerase provided in Example 1 of the present invention has a lower CT value for the DNA sample I to be tested with the same copy number, and still has a good detection effect for the DNA sample II to be tested to which the interfering solution is added, that is, the recombinant DNA polymerase provided in Example 1 of the present invention has excellent DNA polymerase catalytic activity and good anti-inhibition ability.

[0078] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations on the present invention. A person skilled in the art may change, modify, replace and modify the above embodiments within the scope of the present invention without departing from the principles and purpose of the present invention.

Claims

1. A recombinant DNA polymerase, characterized in that The recombinant DNA polymerase comprises an amino acid fragment as shown in SEQ ID NO:1 and / or a variant sequence having more than 90% homology with the amino acid fragment as shown in SEQ ID NO:

1.

2. The recombinant DNA polymerase according to claim 1, characterized in that The amino acid sequence of the recombinant DNA polymerase is shown in SEQ ID NO:

1.

3. The method for preparing the recombinant DNA polymerase according to claim 1 or 2, characterized in that: The preparation method comprises: S1, taking the coding gene of the recombinant DNA polymerase and recombining it into a plasmid vector to obtain a recombinant plasmid; S2, taking the recombinant plasmid and introducing it into a host cell to obtain an enzyme expression strain; S3, taking the enzyme expression strain and inducing expression to obtain the recombinant DNA polymerase.

4. The method for preparing a recombinant DNA polymerase according to claim 3, characterized in that: In step S1, the nucleotide sequence of the gene encoding the recombinant DNA polymerase is shown in SEQ ID NO:

2.

5. The method for preparing a recombinant DNA polymerase according to claim 3, characterized in that: In step S1, the plasmid vector is selected from one or more of pET-28a, pET-24a, pET-24b and pET-24c.

6. The method for preparing a recombinant DNA polymerase according to claim 3, characterized in that: In step S2, the host cell is selected from one or more of Escherichia coli DH5α, Escherichia coli BL21 and Escherichia coli BL21 (DE3).

7. The method for preparing a recombinant DNA polymerase according to claim 3, characterized in that: In step S3, the induced expression includes: taking the enzyme expression strain for expansion culture to obtain a seed solution; taking an inducing expression agent and adding it to the seed solution for induced expression culture to obtain the recombinant DNA polymerase.

8. The method for preparing a recombinant DNA polymerase according to claim 7, characterized in that: The inoculation amount of the enzyme expression strain in the expanded culture is 1-3%, the temperature is 35-40° C., and the time is 12-48 hours; Optionally, the inducing agent is IPTG, and the final concentration added is 0.05-0.2 mM; Optionally, the induction expression culture temperature is 25-30° C. and the time is 16-18 h.

9. Use of the recombinant DNA polymerase according to claim 1 or 2 in probe-based qPCR amplification.

10. A probe method qPCR amplification reaction kit, characterized in that: The kit comprises the recombinant DNA polymerase according to claim 1 or 2.

Citation Information

Patent Citations

  • DNA polymerase and coding gene and application thereof

    CN105462942A

  • Taq DNA polymerase fused with double-stranded DNA binding protein Sto7dm as well as preparation method and application of Taq DNA polymerase

    CN117070492A

  • DCE-KOD DNA polymerase as well as preparation method and application thereof

    CN117821412A

  • DNA polymerase and preparation method therefor and use thereof

    WO2024065925A1